Received Jun 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | GG39D | — |
gave an expired infanrix to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 19-month-old male patient who received DTPa (Infanrix) (batch number GG39D, expiry date 07-JUN-2025) for prophylaxis. On 09-JUN-2025, the patient received Infanrix. On 09-JUN-2025, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: gave an expired infanrix to a patient). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-JUN-2025 Medical Assistant reported that we gave an expired infanrix to a patient, which led to expired vaccine used and reporter wanted to know if need to re-dose or not. The reporter was consented to follow up.